Isoquercetin

DB12665InvestigationalSmall molecule

Isoquercetin has been used in trials studying the treatment of Kidney Cancer, Renal cell carcinoma, Advanced Renal Cell Carcinoma, Thromboembolism of Vein in Pancreatic Cancer, and Thromboembolism of Vein VTE...

Formula / weight: C₂₁H₂₀O₁₂ · 464.3763 g/mol (avg)
Also known as: Kinisoquin
Code names: NSC-115918

Resolves to

Compound

UNII6HN2PC637TCAS482-35-9ChEMBLCHEMBL250450ChEBI68352PubChem5280804KEGGC05623

Structure

InChIKeyOVSQVDMCBVZWGM-QSOFNFLRSA-NSMILESOC[C@H]1O[C@@H](OC2=C(OC3=C(C(O)=CC(O)=C3)C2=O)C2=CC=C(O)C(O)=C2)[C@H](O)[C@@H](O)[C@@H]1O

Targets

P12821ACEP15121AKR1B1

What you can answer from here — as of January 08, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

11Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Isoquercetin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account